Community Enterprise Foundation™ in partnership with the ANZAC Research Institute has launched this public appeal to fund pre-clinical research and the proposed clinical trial of a new treatment for Acute Myeloid Leukemia.
Acute Myeloid Leukemia (AML) is the most common type of adult leukemia and affects the older age group in particular. Whilst there has been some progress in combining established chemotherapy drugs and supportive care for patients, the majority of patients still die of their disease or its complications.
Recent research at the Sydney-based ANZAC Research Institute is creating significant new opportunities in the fight against Leukemia.
Your donation will further that research by conducting a clinical trial in the hope of finding a cure.
Donations of $2 or more are tax deductible.
ANZAC Research Institute Medical Appeal is a management account of Community Enterprise Foundation™ ABN 69 694 230 518, The Bendigo Centre, PO Box 480, Bendigo, Vic 3552.* The Foundation will make distributions by way of grants, following receipt of applications from organisations endorsed with an item 1 Deductible Gift Recipient (DGR)*